Speakers

Expand/Collapse

Andrea Crotti
Principal Scientist - Early Target Discovery
Takeda

Day One

Thursday, August 6, 2020

3:25 pm | Live Speaker Q&A

2:10 pm | Microglia in Spacetime Continuum: Insights from Spatial Transcriptomics

Brad Friedman
Senior Scientist, Department of OMNI Bioinformatics
Genentech

Day Two

Friday, August 7, 2020

12:35 pm | Live Speaker Q&A

11:45 am | Genetic Ablation of Mouse Gpnmb Does Not Alter SynucleinRelated Pathology

Carlos Pedraza
Associate Director Neuroimmunology & MS Therapeutics
Sanofi

Day Two

Friday, August 7, 2020

12:35 pm | Live Speaker Q&A

11:20 am | Developing Remyelination Therapies for Neurodegenerative Diseases

Charlotte Callaghan
Chief Scientific Officer & Patient Insight Manager
Ulysses Neuroscience

Day One

Thursday, August 6, 2020

11:05 am | Live Speaker Q&A

10:40 am | Psychedelics & Neuroinflammation: An Update from Ulysses Neuroscience

Christian Mirescu
Principal scientist, Neuroimmunology
Merck

Day One

Thursday, August 6, 2020

12:50 pm | Live Speaker Q&A

12:25 pm | From Mapping TREM2 Signal Transduction to Downstream Pathway Biomarkers, Leveraging a Toolbox of Genetic & Pharmacological Perturbations

Day Two

Friday, August 7, 2020

9:05 am | Panel Discussion - Translation of Therapeutic Efficacy in Neuroinflammation: Importance of Identifying the Best Biomarkers & Relevant Models

Courtney Easley-Neal
Senior Scientist, In Vivo Biology & Imaging
EISAI

Day Two

Friday, August 7, 2020

9:05 am | Panel Discussion - Translation of Therapeutic Efficacy in Neuroinflammation: Importance of Identifying the Best Biomarkers & Relevant Models

Graham T. Dempsey
Chief Scientific Officer
Q-State Biosciences

Day One

Thursday, August 6, 2020

3:25 pm | Live Speaker Q&A

3:00 pm | Technology-Enabled Drug Discovery Platform Using Human Neuronal Models, Optogenetics & Machine Learning

Juan Pablo De Rivero Vaccari
Research Assistant Professor
University of Miami Miller School of Medicine

Day Two

Friday, August 7, 2020

5:00 pm | Live Speaker Q&A

4:35 pm | Exploring Inflammasome Activation After Traumatic Brain Injury

Kristina Holmberg
Associate Director, Translational and Clinical Biomarkers
EMD Serono

Day Two

Friday, August 7, 2020

9:05 am | Panel Discussion - Translation of Therapeutic Efficacy in Neuroinflammation: Importance of Identifying the Best Biomarkers & Relevant Models

M. Kerry O’Banion
MD, Professor and Vice Chair, Department of Neuroscience
University of Rochester, School of Medicine & Dentistry

Day One

Thursday, August 6, 2020

9:10 am | Kick-Off Panel Discussion - Uncovering the Next Frontier of Neuroimmunology

Maciej Kaliszczak
Senior Scientist, Biomarkers
Biogen

Day Two

Friday, August 7, 2020

9:30 am | Identifying the Right Biomarkers to Track Neuroinflammation

Marie-Eve Tremblay
Canada Research Chair in Neurobiology of Aging and Cognition, Associate Professor, Division of Medical Sciences
University of Victoria

Matthew Simon
Scientist
Denali Therapeutics

Day One

Thursday, August 6, 2020

11:05 am | Live Speaker Q&A

9:50 am | A Brain Penetrant Progranulin Biotherapeutic Rescues Lysosomal and Inflammatory Phenotypes in the Brain of Grn Knockout Mice

Michael Heneka
Professor
University of Bonn Medical Centre

Day Two

Friday, August 7, 2020

3:45 pm | Exploring the NLRP3 Inflammasome in Neurodegenerative Diseases

5:00 pm | Live Speaker Q&A

Michelle Erickson
Research Biologist, VA Puget Sound Healthcare System ; Research assistant professor, Department of Medicine/Division of Gerontology
University of Washington

Pascal Sanchez
Director, Translational Sciences
Denali Therapeutics

Day One

Thursday, August 6, 2020

3:25 pm | Live Speaker Q&A

2:35 pm | Metabolic Perturbations of Phagocytic Microglia in Alzheimer’s Disease Mouse Model

Philip Ashton-Rickardt
Senior Vice President, Immunology
AZTherapies

Day One

Thursday, August 6, 2020

11:05 am | Live Speaker Q&A

10:15 am | Small Molecule & Cell Therapies for Neurodegenerative Diseases

Philip Kong
Associate Director Immuno-Neurology
Alector

Day One

Thursday, August 6, 2020

12:50 pm | Live Speaker Q&A

12:00 pm | Leveraging Genetics to Discover Immune-Modulating Targets for the Treatment of Neurodegenerative Diseases

9:10 am | Kick-Off Panel Discussion - Uncovering the Next Frontier of Neuroimmunology

Rebecca Coll
Principal Investigator, Lecturer in Immunobiology, Wellcome-Wolfson Institute for Experimental Medicine
Queen's University Belfast, UK

Day Two

Friday, August 7, 2020

5:00 pm | Live Speaker Q&A

3:20 pm | Targeting Inflammasomes for the Treatment of Inflammatory Diseases - Potential for CNS Disorders?

Robert Baloh
VP, Global Head of Research in Neuroscience & Rare Diseases
pRED at Roche

Day Two

Friday, August 7, 2020

12:35 pm | Live Speaker Q&A

12:10 pm | Role of C9orf72 in Inflammation & Neurodegeneration

Scott Shandler
Chief Executive Officer
Longevity Biotech

Day Two

Friday, August 7, 2020

2:40 pm | Live Speaker Q&A

1:50 pm | Targeting the Peripheral Nervous System

Shane Liddelow
Assistant Professor, Neuroscience Institute
NYU Langone

Day Two

Friday, August 7, 2020

2:40 pm | Live Speaker Q&A

2:15 pm | Untapping Astrocytes as a Source of New Targets for Neurodegenerative Disorders

SY Seong
Chief Executive Officer, Shaperon ; Professor, Department of Microbiology & Immunology
Seoul National University College of Medicine

Day Two

Friday, August 7, 2020

5:00 pm | Live Speaker Q&A

4:10 pm | GPCR19 Regulates P2X7R-mediated NLRP3 Inflammasomal Activation of Microglia by Amyloid β in Alzheimer’s Diseases

William A. Banks
Associate Chief of Staff - Research & Development, VA Puget Sound ; Professor, Division of Gerontology & Geriatric Medicine, Department of Medicine
University of Washington